Liver Metastasis Unknown Status Phase 4 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0029622 (Liver Metastasis)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01962376Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver MetastasisTreatment